| Dr Anthony John Nicolas, MD | |
|
3601 5th Ave Ste 2b, Pittsburgh, PA 15213-3403 | |
| (412) 605-3924 | |
| (412) 692-4313 |
| Full Name | Dr Anthony John Nicolas |
|---|---|
| Gender | Male |
| Speciality | Rheumatology |
| Experience | 8 Years |
| Location | 3601 5th Ave Ste 2b, Pittsburgh, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407218571 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | MD473332 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Upmc Presbyterian Shadyside | Pittsburgh, PA | Hospital |
| Magee Womens Hospital Of Upmc Health System | Pittsburgh, PA | Hospital |
| Upmc East | Monroeville, PA | Hospital |
| Upmc St Margaret | Pittsburgh, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Pittsburgh Physicians | 8729990239 | 3721 |
News Archive
Nutranomics, Inc.("Nutranomics" or the "Company") is pleased to report that it has received a purchase order for 500,000 capsules of a natural testosterone booster formula recently developed by Nutranomics.
Scientists at The Wistar Institute have shown that an anti-diabetic drug can inhibit the growth of melanoma in older patients by activating an anti-aging gene that in turn inhibits a protein involved in metastatic progression and resistance to targeted therapies for the disease.
UCLA researchers have found that chemotherapy is not commonly used when treating adults with localized sarcoma, a rare type of cancer of the soft tissues or bone.
Insmed Incorporated, a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that the agency has placed a clinical hold on Insmed's phase 3 clinical trials for ARIKACE in Cystic Fibrosis (CF) patients with Pseudomonas lung infections and patients with non-tuberculous mycobacterial (NTM) lung disease.
› Verified 1 days ago
| Entity Name | University Of Pittsburgh Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619935004 PECOS PAC ID: 8729990239 Enrollment ID: O20040308000883 |
News Archive
Nutranomics, Inc.("Nutranomics" or the "Company") is pleased to report that it has received a purchase order for 500,000 capsules of a natural testosterone booster formula recently developed by Nutranomics.
Scientists at The Wistar Institute have shown that an anti-diabetic drug can inhibit the growth of melanoma in older patients by activating an anti-aging gene that in turn inhibits a protein involved in metastatic progression and resistance to targeted therapies for the disease.
UCLA researchers have found that chemotherapy is not commonly used when treating adults with localized sarcoma, a rare type of cancer of the soft tissues or bone.
Insmed Incorporated, a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that the agency has placed a clinical hold on Insmed's phase 3 clinical trials for ARIKACE in Cystic Fibrosis (CF) patients with Pseudomonas lung infections and patients with non-tuberculous mycobacterial (NTM) lung disease.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anthony John Nicolas, MD 3601 5th Ave Ste 2b, Pittsburgh, PA 15213-3403 Ph: (412) 605-3924 | Dr Anthony John Nicolas, MD 3601 5th Ave Ste 2b, Pittsburgh, PA 15213-3403 Ph: (412) 605-3924 |
News Archive
Nutranomics, Inc.("Nutranomics" or the "Company") is pleased to report that it has received a purchase order for 500,000 capsules of a natural testosterone booster formula recently developed by Nutranomics.
Scientists at The Wistar Institute have shown that an anti-diabetic drug can inhibit the growth of melanoma in older patients by activating an anti-aging gene that in turn inhibits a protein involved in metastatic progression and resistance to targeted therapies for the disease.
UCLA researchers have found that chemotherapy is not commonly used when treating adults with localized sarcoma, a rare type of cancer of the soft tissues or bone.
Insmed Incorporated, a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that the agency has placed a clinical hold on Insmed's phase 3 clinical trials for ARIKACE in Cystic Fibrosis (CF) patients with Pseudomonas lung infections and patients with non-tuberculous mycobacterial (NTM) lung disease.
› Verified 1 days ago
Krishna Kancharla, Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5200 Centre Ave, Suite 710, Pittsburgh, PA 15232 Phone: 412-623-6889 | |
Christine Peoples, Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3601 5th Ave, Suite 3b Falk Medical Building, Pittsburgh, PA 15213 Phone: 412-647-6700 | |
Rima Abdel Massih, Rheumatology Medicare: Medicare Enrolled Practice Location: 3601 5th Ave, Suite 3a, Pittsburgh, PA 15213 Phone: 412-648-6273 | |
Dr. Matthew Michael Lander, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 320 E North Ave, Pittsburgh, PA 15212 Phone: 412-359-6500 | |
Allie Dakroub, MD MS Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 200 Lothrop Street, Suite 9 South, Pittsburgh, PA 15213 Phone: 412-692-4888 | |
Katrina Han, Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3601 5th Ave Bldg Suite3a, Pittsburgh, PA 15213 Phone: 412-586-9700 | |
Omar Khaled Osman, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1307 Federal St Ste B300, Pittsburgh, PA 15212 Phone: 412-359-3751 |